On day 15 after treatment, the presence of virus‐specific IgM and IgG was as high as 81% (13/16) and 100% (16/16), respectively, indicating that patients with COVID‐19 generally produce protective antibodies in the early stage of disease.8 The gene discussed is CD40LG; the disease is COVID-19.